• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变特征软件在相关特征上的准确性。

Accuracy of mutational signature software on correlated signatures.

机构信息

Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, 169857, Singapore.

Centre for Computational Biology, Duke-NUS Medical School, Singapore, 169857, Singapore.

出版信息

Sci Rep. 2022 Jan 10;12(1):390. doi: 10.1038/s41598-021-04207-6.

DOI:10.1038/s41598-021-04207-6
PMID:35013428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8748538/
Abstract

Mutational signatures are characteristic patterns of mutations generated by exogenous mutagens or by endogenous mutational processes. Mutational signatures are important for research into DNA damage and repair, aging, cancer biology, genetic toxicology, and epidemiology. Unsupervised learning can infer mutational signatures from the somatic mutations in large numbers of tumors, and separating correlated signatures is a notable challenge for this task. To investigate which methods can best meet this challenge, we assessed 18 computational methods for inferring mutational signatures on 20 synthetic data sets that incorporated varying degrees of correlated activity of two common mutational signatures. Performance varied widely, and four methods noticeably outperformed the others: hdp (based on hierarchical Dirichlet processes), SigProExtractor (based on multiple non-negative matrix factorizations over resampled data), TCSM (based on an approach used in document topic analysis), and mutSpec.NMF (also based on non-negative matrix factorization). The results underscored the complexities of mutational signature extraction, including the importance and difficulty of determining the correct number of signatures and the importance of hyperparameters. Our findings indicate directions for improvement of the software and show a need for care when interpreting results from any of these methods, including the need for assessing sensitivity of the results to input parameters.

摘要

突变特征是由外源性诱变剂或内源性突变过程产生的突变的特征模式。突变特征对于研究 DNA 损伤和修复、衰老、癌症生物学、遗传毒理学和流行病学非常重要。无监督学习可以从大量肿瘤的体细胞突变中推断出突变特征,而分离相关特征是该任务的一个显著挑战。为了研究哪些方法可以最好地应对这一挑战,我们评估了 18 种计算方法,这些方法用于推断 20 个合成数据集上的突变特征,这些数据集包含两种常见突变特征的相关活动的不同程度。性能差异很大,有四种方法明显优于其他方法:hdp(基于层次狄利克雷过程)、SigProExtractor(基于对重采样数据的多次非负矩阵分解)、TCSM(基于文档主题分析中使用的方法)和 mutSpec.NMF(也基于非负矩阵分解)。结果强调了突变特征提取的复杂性,包括确定正确特征数量的重要性和难度,以及超参数的重要性。我们的研究结果为软件的改进指明了方向,并表明在解释这些方法中的任何一种方法的结果时都需要谨慎,包括需要评估结果对输入参数的敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/4715c7252fbf/41598_2021_4207_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/7d47a875052c/41598_2021_4207_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/7d1eeb5224ed/41598_2021_4207_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/58591160ac53/41598_2021_4207_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/4db845730c5f/41598_2021_4207_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/5f535241ce28/41598_2021_4207_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/8a11826fd864/41598_2021_4207_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/4715c7252fbf/41598_2021_4207_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/7d47a875052c/41598_2021_4207_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/7d1eeb5224ed/41598_2021_4207_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/58591160ac53/41598_2021_4207_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/4db845730c5f/41598_2021_4207_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/5f535241ce28/41598_2021_4207_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/8a11826fd864/41598_2021_4207_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/8748538/4715c7252fbf/41598_2021_4207_Fig7_HTML.jpg

相似文献

1
Accuracy of mutational signature software on correlated signatures.突变特征软件在相关特征上的准确性。
Sci Rep. 2022 Jan 10;12(1):390. doi: 10.1038/s41598-021-04207-6.
2
mSigHdp: hierarchical Dirichlet process mixture modeling for mutational signature discovery.mSigHdp:用于突变特征发现的层次狄利克雷过程混合建模
NAR Genom Bioinform. 2023 Jan 23;5(1):lqad005. doi: 10.1093/nargab/lqad005. eCollection 2023 Mar.
3
signeR: an empirical Bayesian approach to mutational signature discovery.signeR:一种经验贝叶斯突变特征发现方法。
Bioinformatics. 2017 Jan 1;33(1):8-16. doi: 10.1093/bioinformatics/btw572. Epub 2016 Sep 1.
4
Analysis of Mutational Signatures Using the mutSignatures R Library.使用mutSignatures R库分析突变特征
Methods Mol Biol. 2023;2684:45-57. doi: 10.1007/978-1-0716-3291-8_3.
5
MutSignatures: an R package for extraction and analysis of cancer mutational signatures.MutSignatures:一个用于提取和分析癌症突变特征的 R 包。
Sci Rep. 2020 Oct 26;10(1):18217. doi: 10.1038/s41598-020-75062-0.
6
Modeling clinical and molecular covariates of mutational process activity in cancer.对癌症中突变过程活性的临床和分子协变量进行建模。
Bioinformatics. 2019 Jul 15;35(14):i492-i500. doi: 10.1093/bioinformatics/btz340.
7
Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.突变图谱和突变特征:深入了解癌症的病因以及 DNA 损伤和修复的机制。
DNA Repair (Amst). 2018 Nov;71:6-11. doi: 10.1016/j.dnarep.2018.08.003. Epub 2018 Aug 24.
8
Bioinformatic Methods to Identify Mutational Signatures in Cancer.生物信息学方法在癌症突变特征识别中的应用。
Methods Mol Biol. 2021;2185:447-473. doi: 10.1007/978-1-0716-0810-4_28.
9
De novo mutational signature discovery in tumor genomes using SparseSignatures.利用 SparseSignatures 在肿瘤基因组中发现新的突变特征。
PLoS Comput Biol. 2021 Jun 28;17(6):e1009119. doi: 10.1371/journal.pcbi.1009119. eCollection 2021 Jun.
10
Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden.高肿瘤突变负荷的非小细胞肺癌患者的突变特征分析。
Respir Res. 2021 Nov 24;22(1):302. doi: 10.1186/s12931-021-01871-0.

引用本文的文献

1
Benchmarking 13 tools for mutational signature attribution, including a new and improved algorithm.对13种用于突变特征归因的工具进行基准测试,包括一种新的改进算法。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbaf042.
2
A comprehensive comparison of tools for fitting mutational signatures.全面比较用于拟合突变特征的工具。
Nat Commun. 2024 Nov 2;15(1):9467. doi: 10.1038/s41467-024-53711-6.
3
Cancer mutational signatures identification in clinical assays using neural embedding-based representations.基于神经嵌入表示的临床检测中癌症突变特征的识别。

本文引用的文献

1
Uncovering novel mutational signatures by extraction with SigProfilerExtractor.通过SigProfilerExtractor提取来揭示新的突变特征。
Cell Genom. 2022 Nov 9;2(11):None. doi: 10.1016/j.xgen.2022.100179.
2
Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers.拓扑异构酶 IIα 的反复突变导致人类癌症中以前未描述的诱变表型。
Proc Natl Acad Sci U S A. 2022 Jan 25;119(4). doi: 10.1073/pnas.2114024119.
3
De novo mutational signature discovery in tumor genomes using SparseSignatures.
Cell Rep Med. 2024 Jun 18;5(6):101608. doi: 10.1016/j.xcrm.2024.101608. Epub 2024 Jun 11.
4
Mutational signatures association with replication timing in normal cells reveals similarities and differences with matched cancer tissues.突变特征与正常细胞复制时间的关联揭示了与匹配的癌症组织的相似和不同之处。
Sci Rep. 2023 May 15;13(1):7833. doi: 10.1038/s41598-023-34631-9.
5
mSigHdp: hierarchical Dirichlet process mixture modeling for mutational signature discovery.mSigHdp:用于突变特征发现的层次狄利克雷过程混合建模
NAR Genom Bioinform. 2023 Jan 23;5(1):lqad005. doi: 10.1093/nargab/lqad005. eCollection 2023 Mar.
6
Uncovering novel mutational signatures by extraction with SigProfilerExtractor.通过SigProfilerExtractor提取来揭示新的突变特征。
Cell Genom. 2022 Nov 9;2(11):None. doi: 10.1016/j.xgen.2022.100179.
7
Aristolochic acid-associated cancers: a public health risk in need of global action.马兜铃酸相关癌症:亟待全球行动的公共健康风险。
Nat Rev Cancer. 2022 Oct;22(10):576-591. doi: 10.1038/s41568-022-00494-x. Epub 2022 Jul 19.
利用 SparseSignatures 在肿瘤基因组中发现新的突变特征。
PLoS Comput Biol. 2021 Jun 28;17(6):e1009119. doi: 10.1371/journal.pcbi.1009119. eCollection 2021 Jun.
4
Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.拷贝数签名分析工具及其在前列腺癌中的应用揭示了不同的突变过程和临床结局。
PLoS Genet. 2021 May 4;17(5):e1009557. doi: 10.1371/journal.pgen.1009557. eCollection 2021 May.
5
MutSignatures: an R package for extraction and analysis of cancer mutational signatures.MutSignatures:一个用于提取和分析癌症突变特征的 R 包。
Sci Rep. 2020 Oct 26;10(1):18217. doi: 10.1038/s41598-020-75062-0.
6
Macroscopic somatic clonal expansion in morphologically normal human urothelium.形态正常的人尿路上皮中的巨观体体细胞克隆扩增。
Science. 2020 Oct 2;370(6512):82-89. doi: 10.1126/science.aba7300.
7
Extensive heterogeneity in somatic mutation and selection in the human bladder.人类膀胱中体细胞突变和选择的广泛异质性。
Science. 2020 Oct 2;370(6512):75-82. doi: 10.1126/science.aba8347.
8
A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependencies.一个用于突变特征分析的实用框架和在线工具显示了组织间的变异和驱动依赖性。
Nat Cancer. 2020 Feb;1(2):249-263. doi: 10.1038/s43018-020-0027-5. Epub 2020 Feb 17.
9
The repertoire of mutational signatures in human cancer.人类癌症中的突变特征谱。
Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3. Epub 2020 Feb 5.
10
Tobacco smoking and somatic mutations in human bronchial epithelium.吸烟与人类支气管上皮体细胞突变。
Nature. 2020 Feb;578(7794):266-272. doi: 10.1038/s41586-020-1961-1. Epub 2020 Jan 29.